Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side.

Furberg C D, Psaty B M

Department of Public Health Sciences, Bowman Gray School of Medicine, Winston-Salem, NC 27157, USA.

Arch Intern Med. 1995 Nov 13;155(20):2157-61.

Abstract

摘要

相似文献

Arch Intern Med. 1995 Nov 13;155(20):2157-61.

MMW Fortschr Med. 2005 Feb 3;147(5):47.

J Hypertens Suppl. 1993 Dec;11(6):S33-5.

Drugs. 1999;57 Suppl 1:2 p preceding 1.

Ugeskr Laeger. 2005 Jan 10;167(2):153-5.

MMW Fortschr Med. 2001 Jun 21;143(25):58.

CMAJ. 1990 Aug 15;143(4):265-7.

J Hypertens Suppl. 1993 Dec;11(6):S27-9.

Blood Press Suppl. 1998;2:23-6.

Recenti Prog Med. 1999 Jan;90(1):4-8.

Cardiovasc Drugs Ther. 1996 Sep;10(4):463-6. doi: 10.1007/BF00051111.

Drugs. 1996 Aug;52(2):232-53. doi: 10.2165/00003495-199652020-00009.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。